Who Paid My Doc
Omnipod
Device Insulin Pump
PDI 10385081120036
General payments
$15,383,018
Research payments
$14,051,709
Through program year 2025, $15,383,018 in general payments and $14,051,709 in research payments were reported against Omnipod (Insulin Pump).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $5,869,278 | 25,976 |
| 2025 | Research | $1,301,911 | 50 |
| 2024 | General | $3,862,461 | 17,948 |
| 2024 | Research | $3,339,821 | 189 |
| 2023 | General | $2,070,874 | 14,629 |
| 2023 | Research | $2,512,421 | 132 |
| 2022 | General | $1,907,937 | 12,018 |
| 2022 | Research | $2,979,221 | 180 |
| 2021 | General | $1,672,468 | 11,134 |
| 2021 | Research | $3,918,335 | 167 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 115 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
81,705 general · 718 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.